Skip to content

MediXall Group, Inc.

CIK 0001601280

← back to feed
Revenue (TTM)
$275.37K
+422.1% YoY Q3 Sep 2025
Net Income (TTM)
−$1.62M
+33.2% YoY Q3 Sep 2025
EPS Diluted (TTM)
−$0.01
+33.3% YoY Q3 Sep 2025
Gross Margin
47.5%
Q3 Sep 2025
Operating Margin
-175.8%
Q3 Sep 2025
Net Margin
-587.1%
Q3 Sep 2025
Free Cash Flow (TTM)
—
Q3 Sep 2025
Cash
$572.43K
Q3 Sep 2025
Total Debt
$170K
Q3 Sep 2025
Shares Outstanding
205.51M sh
Q3 Sep 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Recent filings